You are adding an alert for:
An analysis of the phase 2 trial with intravitreal aflibercept and suprachoroidal triamcinolone acetonide compared to intravitreal aflibercept alone in retinal vein occlusion patients in terms of perfusion status.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: